Literature DB >> 10711583

Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men.

D G Cruess1, M H Antoni, N Schneiderman, G Ironson, P McCabe, J B Fernandez, S E Cruess, N Klimas, M Kumar.   

Abstract

The effects of a 10-week group-based cognitive-behavioral stress management (CBSM) intervention on psychological distress and plasma free testosterone in symptomatic, HIV-seropositive men were examined. Participants were randomized to either CBSM (n = 42) or a wait-list control group (n = 23). Men in the CBSM intervention showed significant increases in testosterone, whereas control participants showed significant decreases. Those participating in CBSM had significant distress reductions, whereas controls showed no such change. Alterations in free testosterone were inversely related to changes in distress states over time, independent of any changes in cortisol. These findings demonstrate that a short-term CBSM intervention increases free testosterone levels among symptomatic, HIV-seropositive men, and alterations in free testosterone are associated with changes in psychological distress observed during CBSM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711583     DOI: 10.1037//0278-6133.19.1.12

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  19 in total

1.  Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers.

Authors:  Guillermo Prado; Daniel J Feaster; Seth J Schwartz; Indira Abraham Pratt; Lila Smith; José Szapocznik
Journal:  AIDS Behav       Date:  2004-09

2.  Stress processes in HIV-positive African American mothers: moderating effects of drug abuse history.

Authors:  Myron J Burns; Daniel J Feaster; Victoria B Mitrani; Christina Ow; José Szapocznik
Journal:  Anxiety Stress Coping       Date:  2008-01

3.  Optimizing the effects of stress management interventions in HIV.

Authors:  Conall O'Cleirigh; Steven Safren
Journal:  Health Psychol       Date:  2008-05       Impact factor: 4.267

4.  Change in urinary cortisol excretion mediates the effect of angry/hostile mood on 9 month diastolic blood pressure in HIV+ adults.

Authors:  Roger C McIntosh; Michael Antoni; Adam Carrico; Ron Duran; Barry E Hurwitz; Gail Ironson; Mary Ann Fletcher; Nancy Klimas; Mahendra Kumar; Neil Schneiderman
Journal:  J Behav Med       Date:  2017-02-02

5.  Improvements in health-related quality of life following a group intervention for coping with AIDS-bereavement among HIV-infected men and women.

Authors:  Kathleen J Sikkema; Nathan B Hansen; Christina S Meade; Arlene Kochman; Rachel S Lee
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

Review 6.  Psychosocial group interventions to improve psychological well-being in adults living with HIV.

Authors:  Ingrid van der Heijden; Naeemah Abrahams; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

Review 7.  Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature.

Authors:  Jennifer L Brown; Peter A Vanable
Journal:  Ann Behav Med       Date:  2008-02-16

8.  The effect of relaxation interventions on cortisol levels in HIV-seropositive women.

Authors:  Deborah Jones; Mary Owens; Mahendra Kumar; Ryan Cook; Stephen M Weiss
Journal:  J Int Assoc Provid AIDS Care       Date:  2014 Jul-Aug

Review 9.  Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials.

Authors:  Adam W Carrico; Michael H Antoni
Journal:  Psychosom Med       Date:  2008-06       Impact factor: 4.312

10.  Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006.

Authors:  Lori A J Scott-Sheldon; Seth C Kalichman; Michael P Carey; Robyn L Fielder
Journal:  Health Psychol       Date:  2008-03       Impact factor: 4.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.